ESPR Operating Income Growth
Esperion Therapeutics Inc · Operating Income Growth
ESPR Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported289.65%period ending
ESPR TTM Operating Income YoY % (-13.00% → 289.65%)
Year-over-year change
High-resolution chart · PNG
ESPR operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 289.6454% | |
| 10.7919% | |
| -278.5476% | |
| -816.3905% | |
| -15.2037% | |
| 134.971% | |
| 110.5678% | |
| 102.914% | |
| 81.261% | |
| 13.3359% | |
| 19.1609% | |
| 17.8675% | |
| 0.9513% | |
| 20.8305% | |
| 27.7702% | |
| 29.0723% | |
| -44.0158% | |
| -86.7689% | |
| -214.5039% | |
| -316.3481% | |
| 49.0034% | |
| -30.3917% | |
| 10.5448% | |
| 12.0281% | |
| -259.6224% | |
| 54.4928% | |
| 48.1% | |
| 55.2436% | |
| 59.5616% | |
| -21.0691% | |
| -14.4519% | |
| -35.1672% | |
| -71.1917% | |
| -121.9068% | |
| -165.5136% | |
| -137.8512% | |
| -91.2851% | |
| -52.1783% | |
| -30.1238% | |
| -28.7174% | |
| -34.4023% | |
| -38.1405% | |
| -26.2602% | |
| -33.079% | |
| -45.6124% | |
| -59.1655% | |
| -140.9318% | |
| -152.9097% | |
| -140.3965% | |
| -123.0423% | |
| -6.4356% | |
| 33.1876% | |
| 51.3205% | |
| 3.7324% | |
| -1.4309% | |
| 5.9772% | |
| 10.303% | |
| 6.125% | |
| 13.1084% | |
| 4.2532% | |
| -13.002% |